ArticleFrontiers in public health2025
Influenza vaccination in Austria from 1982 to 2023-Decades of consistent ignorance and refusal.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Influenza still tops the list of vaccine-preventable diseases and deaths in Austria. For more than four decades, Austria has grappled with persistently low rates of influenza vaccination, despite the clear availability of vaccines and recommendations from health authorities. This phenomenon is characterized by widespread public hesitation and systemic challenges within the healthcare system, resulting in a pronounced gap between vaccination campaigns and actual uptake. An average epidemic results in approximately 350,000-400,000 cases and 1,300 deaths annually in Austria. Despite this, vaccination rates remain alarmingly low, with coverage slightly above 10%, making it one of the lowest worldwide. Three earlier publications have reported the Austrian influenza vaccine use over several time periods between 1982 and 2015. This study extends these findings, analyzing data from eight additional influenza seasons (2016/17 to 2023/24), offering insights into over four decades of influenza vaccine utilization in Austria. Material and methods: Vaccine use data, presented as vaccine dose distributions per 1,000 population and vaccination rate percentages, from international studies and from the Austrian market only, were used. Results: Austria has consistently ranked among the countries with the lowest vaccine distribution rates; the number peaked in 2006 at 142 doses per 1,000. Since 2007, there has been a steady decline to 62 doses per 1,000 in the 2015/16 season, like levels observed in the mid-1990s. In the following years, a slight increase was observed to 85 doses per 1,000 in the 2019/20 season. During the 1st year of the COVID-19 pandemic, the number of doses distributed more than doubled to 221 doses per 1,000, before falling again in subsequent seasons. Conclusion: Despite comprehensive vaccination recommendations, influenza vaccination remains significantly undervalued by the Austrian population and many sectors of the health care system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.